arginine has been researched along with Carcinoma, Papillary in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahiskanali, R; Akalin, S; Avsar, M; Bircan, R; Cirakoglu, B; Deyneli, O; Gozu, H; Gulluoglu, B; Narin, Y; Ones, T; Sahin, S | 1 |
| Bosi, E; Cappelletti, C; Carrera, P; Cattaneo, C; Di Rosa, E; Ferrari, M; Franchi, GM; Manzoni, MF; Piani, C; Sartorio, SM | 1 |
| Ingargiola, GB; Pavone-Macaluso, M; Tripi, M | 1 |
| Pavone-Macaluso, M | 1 |
| Caramia, G; Messana, V; Pavone-Macaluso, M; Rizzo, FP | 1 |
| Kenis, Y; Rozencweig, M; Schulman, CC; Staquet, M; Sylvester, R | 1 |
| Mechl, Z; Rovný, F; Sopková, B | 1 |
| Frankendal, B; Sorbe, B; Wolmesjö, E | 1 |
3 trial(s) available for arginine and Carcinoma, Papillary
| Article | Year |
|---|---|
Cooperative studies of chemoprophylaxis after transurethral resection of bladder tumors.
Topics: Antineoplastic Agents; Carcinoma, Papillary; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Humans; Multi-Institutional Systems; Neoplasm Recurrence, Local; Prognosis; Pyridoxine; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1983 |
Preliminary evaluation of VM-26: a new epipodophyllotoxin derivative, in the treatment of urogenital tumours.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Papillary; Chemotherapy, Cancer, Regional Perfusion; Clinical Trials as Topic; Drug Evaluation; Humans; Infusions, Parenteral; Leiomyosarcoma; Male; Mitosis; Neoplasm Metastasis; Podophyllotoxin; Prostatic Neoplasms; Teniposide; Teratoma; Testicular Neoplasms; Therapeutic Irrigation; Urinary Bladder Neoplasms | 1975 |
EORTC randomized trial for the adjuvant therapy of T1 bladder carcinoma.
Topics: Carcinoma, Papillary; Clinical Trials as Topic; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Podophyllotoxin; Postoperative Care; Remission, Spontaneous; Teniposide; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms | 1976 |
5 other study(ies) available for arginine and Carcinoma, Papillary
| Article | Year |
|---|---|
Does a Leu 512 Arg thyrotropin receptor mutation cause an autonomously functioning papillary carcinoma?
Topics: Amino Acid Sequence; Arginine; Base Sequence; Carcinoma, Papillary; Female; Goiter, Nodular; Humans; Leucine; Mutation; Polymorphism, Single-Stranded Conformational; Radionuclide Imaging; Receptors, Thyrotropin; Thyroid Neoplasms; Thyroidectomy | 2004 |
A novel MEN1 gene mutation.
Topics: Arginine; Carcinoma, Papillary; Female; Germ-Line Mutation; Glycine; Humans; Middle Aged; Multiple Endocrine Neoplasia Type 1; Mutation, Missense; Pancreatic Neoplasms; Proto-Oncogene Proteins | 2008 |
Chemotherapy of bladder tumours.
Topics: Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Papillary; Humans; Neoplasm Metastasis; Papilloma; Recurrence; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1978 |
VM 26 (4-demethyl-epipodophyllotoxin-beta-d-thenylidine glucoside) in the treatment of urinary bladder tumors.
Topics: Carcinoma, Papillary; Humans; Podophyllotoxin; Recurrence; Remission, Spontaneous; Teniposide; Time Factors; Urinary Bladder Neoplasms | 1977 |
VM-26-vincristine-cisplatin combination chemotherapy in the treatment of primary advanced and recurrent endometrial carcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Teniposide; Uterine Neoplasms; Vincristine | 1989 |